Join our newsletter

Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM

APILAM informs you that the personal data that you provide to us by filling in this form will be treated by APILAM as responsible for this web. The purpose of the collection and processing of personal data that we request is to manage the registration of this subscription and send periodic bulletins with information and prospective offer of products or services.

Legitimation: Consent of the interested party

As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).

The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.

You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.

You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.

Last update: Aug. 25, 2019

(C8H9O4S)(C8H8O4S)n(C7H7O4S)

Very Low Risk for breastfeeding

Safe. Compatible.
Not risky for breastfeeding or infant.

Antiséptico tópico dermatológico y ginecológico. Utilizado también en enjuagues orales y para el tratamiento de aftas bucales y como hemostático en hemorroides.

A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna.

La pequeña dosis y la escasa absorción plasmática de la mayoría de preparaciones dermatológicas y ginecológicas tópicas hacen poco probable el paso de cantidad significativa a leche materna.
En el caso del policresuleno, el fabricante asegura que no hay absorción sistémica y que es compatible con la lactancia (Takeda 2018, CecMed 2018).
En caso de uso oral, hay que aplicarlo muy diluido y limpiarlo a los pocos minutos para evitar irritaciones y quemaduras locales (Wardhany 2016).

Producto con muy escasas referencias bibliográficas y/o muy antiguas.

Alternatives

We do not have alternatives for (C8H9O4S)(C8H8O4S)n(C7H7O4S) since it is relatively safe.

Very Low risk.

Safe. Compatible. Not risky for breastfeeding or infant.

More information

Low Risk.

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

More information

High Risk.

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

More information

Very High Risk.

Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding.

More information

Very Low risk.

Safe. Compatible. Not risky for breastfeeding or infant.

More information

Low Risk.

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

More information

High Risk.

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

More information

Very High Risk.

Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding.

More information

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

DONATE NOW

Other names

(C8H9O4S)(C8H8O4S)n(C7H7O4S) is Policresulen in Molecular formula.

Is written in other languages:

بوليكريسولان (Arabic)
Поликрезулен (Cyrillic)
聚甲酚磺醛 (Chinese)
ポリクレスレン (Japanese)
α-(4-Hydroxy-2-methyl-5-sulfobenzyl)-ω-(4-hydroxy-5-sulfo-o-tolyl)poly[(4-hydroxy-2-methyl-5-sulfo-m-phenylene)methylene]; 2-Hydroxy-p-toluenesulfonic acid, polymer with formaldehyde (Chemical name)
D08AE02; G01AX03 (ATC Code/s)

(C8H9O4S)(C8H8O4S)n(C7H7O4S) is also known as

Groups

(C8H9O4S)(C8H8O4S)n(C7H7O4S) belongs to these groups or families:

Tradenames

Main tradenames from several countries containing (C8H9O4S)(C8H8O4S)n(C7H7O4S) in its composition:

List of 13 tradenames

Albocresil™
Albothyl™
Albothyl (爱宝疗)™
Emaftol™
Faktu™. Contains other elements than (C8H9O4S)(C8H8O4S)n(C7H7O4S) in its composition
Negatol™
Negatol Dental™
Nelex™
Proctoacid™. Contains other elements than (C8H9O4S)(C8H8O4S)n(C7H7O4S) in its composition
Proctox-H™. Contains other elements than (C8H9O4S)(C8H8O4S)n(C7H7O4S) in its composition
Proctyl™. Contains other elements than (C8H9O4S)(C8H8O4S)n(C7H7O4S) in its composition
Vagothyl™
Vagothyl (Ваготил)™

Pharmacokinetics

Variable	Value	Unit
Oral Bioavail.	0	%
Molecular weight	> 588	daltons

References

Takeda. Policresuleno (Albothyl). Ficha técnica. 2018 Full text (in our servers)
CecMed. Policresuleno (Cervixept). Ficha técnica. 2018 Full text (in our servers)
Wardhany, Indriasti & Wimardhani, Yuniardini & Soegyanto, Anandina. Oral mucosal burn caused by topical application of 36% policresulen solution - a case series. J Int Dental & Medical Res. 2016 Special Issue, Vol. 9, p387-391. 2016 Full text (in our servers)

Total visits

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

Write to us at elactancia.org@gmail.com